Division of Nephrology and Hypertension Archive — Page 4 of 9
-
May 27, 2021
Arroyo awarded Harold Amos Medical Faculty Development grant from Robert Wood Johnson Foundation
Juan Pablo Arroyo, MD, PhD, has been awarded the Harold Amos Medical Faculty Development Grant from the Robert Wood Johnson Foundation, the nation’s largest philanthropy dedicated solely to health. -
April 29, 2021
Genetic ancestry and hypertension risk
Racial disparities in hypertension risk are due in part to genetic differences between ancestries, Vanderbilt investigators find in a study of participants in the Million Veteran Program. -
April 15, 2021
New insights into kidney development
Integrin-linked kinase, a central component of a complex that coordinates cell signaling involved in migration, proliferation and cell death, plays a role in kidney development and epithelial cell function. -
March 25, 2021
Spirituality may help reduce end-stage kidney disease risk
Researchers from Vanderbilt’s Division of Nephrology and Hypertension have identified an under-studied characteristic that may have a protective effect on end-stage kidney disease (ESKD) risk among vulnerable populations. -
October 15, 2020
Brain blood vessel response to hypoxia
The brain’s response to low oxygen — growth and remodeling of blood vessels — involves certain cell types and molecular pathways, Vanderbilt researchers have discovered. -
October 5, 2020
Clue to diabetic kidney disease
Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication. -
July 30, 2020
Protein study may be key to treating fibrotic diseases
A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.